Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Cheryl J. Fitzer-Attas"'
Autor:
Daisy Abreu, Jennifer Ware, Nellie Georgiou-Karistianis, Blair R. Leavitt, Cheryl J. Fitzer-Attas, Raquel Lobo, Ana Raquel Fernandes, Olivia Handley, Karen E. Anderson, Julie C. Stout, Cristina Sampaio
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Introduction: An understanding of the clinimetric properties of clinical assessments, including their constraints, is critical to sound clinical study and trial design. Utilizing data from Enroll-HD—a global, prospective HD observational study and
Externí odkaz:
https://doaj.org/article/4af292b6ce0a4ba7b3b03db1ac9ee739
Autor:
Patrik, Fazio, Martin, Schain, Ladislav, Mrzljak, Nahid, Amini, Sangram, Nag, Nabil, Al-Tawil, Cheryl J, Fitzer-Attas, Juliana, Bronzova, Bernhard, Landwehrmeyer, Cristina, Sampaio, Christer, Halldin, Andrea, Varrone
Publikováno v:
NeuroImage. 152
Phosphodiesterase 10A enzyme (PDE10A) is an important striatal target that has been shown to be affected in patients with neurodegenerative disorders, particularly Huntington´s disease (HD). PDE10A is expressed on striatal neurones in basal ganglia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6995ab0bfc2f0cda1815ae5c35760051
https://pubmed.ncbi.nlm.nih.gov/28254508
https://pubmed.ncbi.nlm.nih.gov/28254508
Autor:
Olivier, Rascol, Robert A, Hauser, Fabrizio, Stocchi, Cheryl J, Fitzer-Attas, Yulia, Sidi, Victor, Abler, C Warren, Olanow
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 31(10)
The Attenuation of Disease progression with Azilect GIven Once-daily (ADAGIO) delayed-start study demonstrated a benefit of early-start treatment with rasagiline 1 mg/day versus delayed-start treatment in PD. This follow-up study aimed to assess whet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1621c15dd95361d600eae4acca533e84
https://pubmed.ncbi.nlm.nih.gov/27431201
https://pubmed.ncbi.nlm.nih.gov/27431201
Autor:
Fanying Meng, Anthony L. DeFranco, Alexander J. Finn, Malcolm Lowry, Cheryl J. Fitzer-Attas, Mary T. Crowley, Clifford A. Lowell
Publikováno v:
The Journal of Experimental Medicine
Macrophage Fcgamma receptors (FcgammaRs) mediate the uptake and destruction of antibody-coated viruses, bacteria, and parasites. We examined FcgammaR signaling and phagocytic function in bone marrow-derived macrophages from mutant mice lacking the ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6909c67657e8594b75d8d89022e75630
https://doi.org/10.1084/jem.191.4.669
https://doi.org/10.1084/jem.191.4.669
Publikováno v:
The Journal of Immunology. 160:145-154
T cells of tumor bearers often show defective TCR-mediated signaling events and, therefore, exhibit impaired immune responses. As such, patients with heavy tumor burden are often not amenable to adoptive T cell therapy. To overcome this limitation, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ebadc85b3c8877ce733ce84989ecf12
https://doi.org/10.4049/jimmunol.160.1.145
https://doi.org/10.4049/jimmunol.160.1.145
Autor:
P. S. Costello, Mary T. Crowley, Martin R Turner, Clifford A. Lowell, Cheryl J. Fitzer-Attas, Anthony L. DeFranco, Victor L. J. Tybulewicz, Fanying Meng
Publikováno v:
The Journal of Experimental Medicine
Receptors on macrophages for the Fc region of IgG (FcgammaR) mediate a number of responses important for host immunity. Signaling events necessary for these responses are likely initiated by the activation of Src-family and Syk-family tyrosine kinase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b289e74429defe7733baaa7d462c280e
http://hdl.handle.net/10044/1/57997
http://hdl.handle.net/10044/1/57997
